Fund details
Launched as Google Ventures in 2009, GV operates as an independent VC firm backed by Alphabet, focusing on supporting founders at the earliest stages of company-building.
Go to profile
Partners related to this fund
Krishna Yeshwant
General Partner
Krishna co-leads the GV investing team and heads their Life Sciences group. He has been an investor across the healthcare spectrum, including health IT, devices, diagnostics, and therapeutics. He led GV’s early investments in companies such as Adimab, Foundation Medicine, Editas, Beam Therapeutics, and One Medical.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Canada
Europe
Investment ranges
$500K - $1M
$1M - $3M
$3M - $10M
$10M - $50M
Focus areas
Enterprise
Consumer
Biotech
Deeptech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
